Sign In
TechNet-21 - Forum
This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.
Featured Posts
New TechNet-21 Resource Library
Moderator
In
We are pleased to announce the launch of our new resource library available here: http://bit.ly/vaccine_library
What can you expect from the library:
- A faster (less than 1 second!) and more powerful search engine with more filters (type of document, category, language, disease, author...)
- More documents as our Cold Chain Equipment documents are now also available in the library
- You can now mass download your search result into a zip that includes a csv file with the resources info and all the uploaded files attached
- It's optimized for mobile devices
- You can choose between two grid views or a list presentation
- You can easily post comments on each document page
- The downlaod page offers a suggestion of related resources
And as before, if you see there's a relevant missing document, you can upload it in the resource library to make it available to all!
Our resource library is one of the most exhaustive immunization-related online library, we hope you'll enjoy it!
Please do leave a post here if you have any question!
New Topic Page: Dose Per Container (DPC)
The recently published topic page on dose per container (DPC) provides a range of useful resources from case studies to decision support documents to better understand the effects of DPC on six immunization system components; namely operational costs, timely coverage, safety, wastage, and policy/correct use.
The Dose Per Container Partnership (DPCP) is excited to share these resources and hope that you will find them useful in your work with the immunization system as a whole. We encourage you to share your thoughts with us to continue the conversation on DPC.
Nigeria Ex-Scholars Accelerating towards Impact
Nigeria EX-Scholars on the way to creating lasting impact
WHO Scholar program a learning approach to bring sharing new innovations and intervention guideline to improving immunization system all over the globe has been widely received by Nigerians and other scholars in different countries across the globe.
The WHO Scholar Program have deepen our knowledge in immunization system and how to improve in immunizations coverages in our different context and further creating lasting impact. In fact we now thinking differently outside the box towards bringing innovative ideas and strategies that will improve immunization program quality and coverage. This has been possible through having different learning methodology like the open webinars, short videos by experience course contributors from WHO, UNICEF, CDC etc, peer review process, sharing of guidelines by course team, whatsup platform, and other platform created by the Geneva Learning Foundation.
Nigeria Ex-scholars who have completed one or more of the WHO Scholar courses have come together to meet digitally to brainstorm on the way forward towards implementation of the courses they have learn so far. They have decided to take a holistic approach towards Impact accelerators exercise, by this approach they have decided to harmonized all projects from the different courses such as Immunization coverage survey, Data Improvement plan, using Global Routine Immunization strategy practice to improve coverage, and reducing inequity and improving coverage into 4 harmonized documents with actionable recommendation and simplified strategies.
Nigeria Ex-scholars have decided to go beyond learning, acquiring of certificate to creating lasting impact in the world of immunization in her country and globally, that will have significant impact in improving immunization coverage and strengthen Health system. This is an innovation!.
Nigeria Ex-Scholars are leading the way for other countries’ scholars to follow, this is becoming more interesting because of high level of commitment and enthusiasm that have been seen by Nigeria ex-scholars and others towards impact acceleration. We continue to brace up until we make impact.
Bravo to Nigerians Ex-scholars
Vaccination Record - A passive Monitoring Tool
Dear all
Vaccination records from private vaccination service providers give us very good opportunities to passively monitor the quality of the service in terms of timeliness and completeness. Monitoring observations are shared with the specific service provider, corresponding government planning unit, stakeholders of both the sectors for appropriate actions. The recent CME workshop arranged by native district IAP in collaboration with Government and WHO country office titled “Confusion to Clarity” is an example of proactive purposive approach by the private sector. Hope the attached one of the several qualitative examples will make it much clearer and justify the CME workshop, providing documentary evidence to replicate and scale up similar workshops in all districts and state level.
Being passive monitoring, this is a zero budget programme which all dedicated vaccination clinics can easily do, helping to improve the quality of service delivery to attain the goals and objectives of RI programme.
Best wishes
Dr Holla
KVG Medical College
OPEN WEBINAR- 15/07/2019 - Enquêtes de couverture vaccinale post-campagne (après une ASV) - en français
L’événement: Enquêtes de couverture vaccinale post-campagne (après une ASV)
Lundi 15 juillet 2019 à 16 heures de Genève (vérifier l'heure)
Lien d’inscription | Webinar ID: 146-979-176
Une ASV est toute activité vaccinale conduite en plus des services de vaccination systématique.
Les enquêtes de couverture vaccinale post-campagne: Quelles sont leurs spécificités? Comment utiliser le Manuel de référence de l’OMS pour les enquêtes de couverture vaccinale par sondage en grappes afin de mieux les préparer? Quelles sont les nouvelles ressources disponibles pour améliorer leur qualité? Avec la participation de: Dr. Carolina Danovaro (OMS) Dr. Mamadou Diallo (UNICEF) Dr. David Koffi (ADS) et Dr. Carol Tevi-Benissan (OMS) Cet événement est ouvert à tous, sans condition. Il sera également diffusé via Facebook Live sur cette page. Cliquez ici pour participer à l'événement…
Lien d’inscription | Webinar ID: 146-979-176
Une ASV est toute activité vaccinale conduite en plus des services de vaccination systématique.
Les enquêtes de couverture vaccinale post-campagne: Quelles sont leurs spécificités? Comment utiliser le Manuel de référence de l’OMS pour les enquêtes de couverture vaccinale par sondage en grappes afin de mieux les préparer? Quelles sont les nouvelles ressources disponibles pour améliorer leur qualité? Avec la participation de: Dr. Carolina Danovaro (OMS) Dr. Mamadou Diallo (UNICEF) Dr. David Koffi (ADS) et Dr. Carol Tevi-Benissan (OMS) Cet événement est ouvert à tous, sans condition. Il sera également diffusé via Facebook Live sur cette page. Cliquez ici pour participer à l'événement…
Decommissioning of old and obsolete CCE
Dear TechNet-21 community,
As most of you know, countries are focusing on the cold chain expansion, but disposal of old & obsolete cold chain equipment are also one of the identified gaps. Due to this fact we are planning to work on it, could you share with us country experience or guideline on the decommissioning of old and obsolete CCE?
Thanks,
Henok
Introduction
My name is Abdullahi Umar an Immunization Information System and coverage specialist, working with African Field Epidemiology Network deployed to Borno State, Nigeria with the main purpose of supporting the state on the Implementation of DHIS2.
Impact of cross learning visit and retro visit - a mini successful model
Dear viewers
KVG team wishes to share the "mini" successful story of one page with photos for information.
Cross learning visit to an established "Demo-Site", practicing the acquired operational knowledge in the home institution on returning, retro visit for further fine tuning is one of the simplest, surest public health interventions in rapidly scaling up / replicating right practices for the successful outcome of a programme.
Attached is "mini" example.
Way forward: Opportunities to expand the benefit to wider geographical area in the state and the country.
With warm regards
Holla n Team
CME on Confusion to clarity in child Immunization
Dear all
I wish to share the highlights of above CME held today (30-06-2019) by the IAP Dakshinakannad as felt need in association with District Health and Family Welfare officer, SMO WHO country office Mangaluru, KVG Medical College, Yenepoya Medical College, KVG Medical College Sullia, ~78 participants - mainly private practitioners.
wish you happy reading
Holla
Frequency of Outreach Vaccination efforts
Jay Rajgopal
In
What is a typical frequency of outreach operations for EPI vaccinations? Monthly, quarterly, every six months, annually? Are there any prescribed standards for this? On a related note, are outreach operations typically scheduled at the same locations or do they shift these from place to place? Thanks for any pointers.
Next meeting TechNet-21
Hello
Any idea about the next meeting Technet 21 : Dates, country?
Best Regards
Ramzi
An Alternative to Energy Harvesting Controls (EHC)
EHC is a valuable method of obtaining excess energy from an SDD refrigerator, however an autonomous solar direct system powering USB ports is a simpler, more reliable and less expensive method of providing auxiliary power.
USB ports can be powered directly from a solar panel, no batteries are required. The conversion device is simple and reliable; these ports can be used for charging cell phones, ipads, lights and AA or AAA batteries.There are a large variety of lights available: lanterns, directional lights, headlamps and lights with motion sensors. Jump starting car batteries can also be charged by a USB port. If desired a 12 volt port could also be incorporated to power a fan and if needed a 12 Volt battery. USB charged devices typically require an average of 3 watts of charging power. Twelve watts of solar per USB port will supply reliable charging at the beginning and end of the solar day and during overcast conditions. For 4 ports a 48 watt module would provide highly reliable power. This would charge at least 8 devices each day.
Having an autonomous system for auxiliary loads has a number of advantages:
- With EHC’s the controller is designed for a specific brand and model of refrigerator. An autonomous solar system will work with all types of refrigerators.
- As a consequence of working with only a specific brand and model of refrigerators the aggregate cost of testing will be very high.
- Testing must also be carried out for each specific type of load, resistive, battery charging, etc.
- Trouble shooting system in the field will be much simpler with an autonomous power system there will not be the possibility of interaction between the two systems.
- The autonomous system with USB ports would be inexpensive and easy to install.
- When solar conditions are poor the autonomous system will provide more reliable power for a greater portion of the day. I would be glad to discuss the pros and cons of this system further. EHC’s are a good concept because a 60 watt load is typically powered by a 300 watt array. However, I think a separate autonomous system is a more appropriate solution.
- As a consequence of working with only a specific brand and model of refrigerators the aggregate cost of testing will be very high.
- Testing must also be carried out for each specific type of load, resistive, battery charging, etc.
- Trouble shooting system in the field will be much simpler with an autonomous power system there will not be the possibility of interaction between the two systems.
- The autonomous system with USB ports would be inexpensive and easy to install.
- When solar conditions are poor the autonomous system will provide more reliable power for a greater portion of the day. I would be glad to discuss the pros and cons of this system further. EHC’s are a good concept because a 60 watt load is typically powered by a 300 watt array. However, I think a separate autonomous system is a more appropriate solution.
Learning is a continuous process - an example
Dear viewers
Learning is a continuous prosess, attached is one such example applicable for the entire country with ~28000 planning units; presenting the attachment as an evidence for continuous learning.
With best wishes
Holla n Team
New Missed Opportunities for Vaccination topic page on TechNet
We are pleased to announce the launch of the topic page for Missed Opportunities for Vaccination (MOV) on TechNet: https://www.technet-21.org/en/topics/mov
The MOV topics page includes tables with information about:
• MOV publications
• MOV training material
• Interventions to reduce MOV by addressing health worker knowledge, attitudes and practice
• Interventions to reduce MOV by addressing health systems issues
• Interventions to reduce MOV by addressing the demand-side (caregiver behaviours) The launch of this page also coincides with the finalization of the Intervention guidebook for implementing and monitoring activities to reduce Missed Opportunities for Vaccination (MOV). The purpose of the Intervention Guidebook is to provide practical advice on how to ensure a smooth transition between Steps 6 and 7, and guidance to countries in implementing the final steps (Steps 7–10) of the 10-step MOV strategy. These steps will help putting the assessment findings into practice. The guide also includes frequent reasons for MOV, an overview of potential interventions to reduce MOV, examples of job aids and other materials for use at the health facility level, and guidance for activities and processes to explore and design locally tailored interventions to reduce MOV. As new publications, training material and interventions to reduce MOV become available, we will update them to the relevant table. If there are any interventions not included in the guide or in the tables, let us know! I hope you enjoy the MOV topics page and if you like further information related to MOV it can be found here: https://www.who.int/immunization/programmes_systems/policies_strategies/MOV/en/ A big thank you to Dan Brigden, Alex Pascutto and Alex Lee for their support in developing this page!
• MOV training material
• Interventions to reduce MOV by addressing health worker knowledge, attitudes and practice
• Interventions to reduce MOV by addressing health systems issues
• Interventions to reduce MOV by addressing the demand-side (caregiver behaviours) The launch of this page also coincides with the finalization of the Intervention guidebook for implementing and monitoring activities to reduce Missed Opportunities for Vaccination (MOV). The purpose of the Intervention Guidebook is to provide practical advice on how to ensure a smooth transition between Steps 6 and 7, and guidance to countries in implementing the final steps (Steps 7–10) of the 10-step MOV strategy. These steps will help putting the assessment findings into practice. The guide also includes frequent reasons for MOV, an overview of potential interventions to reduce MOV, examples of job aids and other materials for use at the health facility level, and guidance for activities and processes to explore and design locally tailored interventions to reduce MOV. As new publications, training material and interventions to reduce MOV become available, we will update them to the relevant table. If there are any interventions not included in the guide or in the tables, let us know! I hope you enjoy the MOV topics page and if you like further information related to MOV it can be found here: https://www.who.int/immunization/programmes_systems/policies_strategies/MOV/en/ A big thank you to Dan Brigden, Alex Pascutto and Alex Lee for their support in developing this page!
immunization schedule for children who have missed the routine immunization
What are the vaccines that could be given to children who have missed their immunization as scheduled? Some children come at 1 year, 2 years and even at 3 years of age without receiving any vaccine or only a few of them. I would like to know what vaccines could be given at various ages for children who have missed required injections of vaccines.
Dr. Dhrupthob sonam
Enlightening the CUSTODIANS of Mantoux Test [Tuberculin Skin Test – TST]
Dear viewers
we feel proud to share the following.
Though the decision making is with the professionals, many skilled procedures like parenteral administration of medicines through ID / SC / IM / IV, insertion of nasogastric tube, IV canula proper use of AMBU (artificial manual breathing unit) bags with or without oxygen for resuscitating asphyxiated newborn, preparing slides, proper staining and reading slides under microscope to look for Malaria parasites, mycobacteria etc. are with the nursing staff / lab technicians. Hence, adequate training, retraining, periodic supportive supervision on a regular basis, supporting peer education for rapid expansion & sustenance of capacity building certainly strengthens implementation of national health programmes.
Legacy from the polio eradication programme, president success stories are very much useful in timely elimination of Tuberculosis.
Coming to the point: As shared on 01st June, proper administration of tuberculin as per the “Rights” in all thematic areas by the staff nurses / lab technicians [TST testers] decides the outcome of the test: induration or no induration which influences the decision of treating doctor and the fate of the patients who adore doctor’s decision; the foundation of programme success.
On observing and sharing innumerable lapses in administering TST in the last two years, author was asked to conduct a CME to the “TST testers” of medical colleges of Dakshina Kannada district which was held on 01 June and to share the experiences as feedback in the State Task Force (STF) meeting held on 07 June for way forward. We wish to share the feedback presented on 7th June with the viewers of techNet-21.
Way forward: The ZTF chair / STF chair / JD and DD tuberculosis of Karnataka state on the spot expressed that one day training has to be conducted for the “TST testers” of all Medical Colleges in batches of 18-21 at the Demosite established in KVG Medical College, functioning since April 2016. We trained 144 Staff Nurses of Mobile Medical Units (MMU’s) of 27 districts of Karnataka in Extended Immunogram between 11-03-2017 & 10-06-2017. Management of KVG Medical College gracefully provided free accommodation to the participants. We are now ready to train the TST “Testers” of all Medical Colleges of Karnataka.
Acknowledgement: India is committed, Karnataka is more committed. KVG team is heartily indebted to the ZTF / STF chairs, JD / DD-TB Karnataka, WHO consultants, all the RNTCP nodal officers of all the Medical Colleges of Karnataka & DTO Dakshina Kannada.
Attached is the feedback presented in the STF meeting at Bangalore on 7th June 2019.
with best wishes
Holla n Team
Given mOPV2 and bOPV to eligible child during campaign
Dr Khalid
In
Dear all
I encountered operational challege were during SIA, specifically OBR using mOPV2 antigen. I observed that the fixed post team were given only bOPV which is the right antigen for routine while ignoring the purpose of the campaign (mOPV2 not given). They were intructed to give both mOPV2 and bOPV concurrently in other to ensure children received RI and SIA doses. When we reffered to the stakeholders it was revealed that guideline stipulated that, child should receive only mOPV2 and resheduled for bOPV next contact. i have little imformation that needs clarification from immunzation experts and/or refference materials for capacity building in support of the guideline.
1. What is the possible consequence of given mOPV2 and bOPV at same time? any scientific justification.
2. Weighing the risk of missed oppurtunities and combining both antigens at same, which one should i prioritised?
Thanks alot waiting for your input.
CME Workshop on "Diagnostic Role" and the "Rights" to be observed about Mantoux test
Dear viewers
Greetings from KVG team to the esteemed viewers of techNet community. 01 June was a great day for the KVG team as we realized almost 2 years old dream.
In public health, proactive approach, perseverance, social services do have its impact at least in the long term. Since 13 June 2017 whenever I visited a Medical College, with the help of authorized faculties visited the Mantoux testing centers and jointly observed lot of aberrations from the standard guidelines. Joint observation helped a great in instantaneous corrections as it does not require a feedback and no service provider consciously repeats / continues grievous programmatic errors. We feel blessed and honored as we are asked by the government of Karnataka to conduct a small scale CME on TST as a pilot workshop for way forward.
We wish to share the high lights of the CME with the esteemed viewers for further needful.
With warm regards
Holla n Team
HLN Releases Update to its Award Winning Open Source Immunization Forecaster
Noam Arzt
In
On May 31, 2019, HLN released a new version (v1.17.1) of the Immunization Calculation Engine (ICE). ICE is a state-of-the-art open-source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR) and Personal Health Record (PHR) Systems.
This version includes:
Improvements to handling of duplicate shots. Duplicate shots typically represent "bad data" that has been passed into the ICE service. For two or more duplicate shots on the same day, ICE will select the vaccine that makes the most sense for the circumstance. See Two Shots, Same Vaccine Group, Same Day Exception Rules for the specifics on how this is handled for each vaccine group.
Logic updates to DTP, HPV, and Zoster vaccine groups. See Release Notes for details.
Pneumococcal interval fix in the Adult Series where (under certain circumstances) the PPSV to PPSV 5 year recommended interval is not being applied when there is a valid PCV shot in between the PPSV shots.
The full software release is available for download at https://cdsframework.atlassian.net/wiki/display/ICE/Downloads. A revised ICE Implementation Guide is also available.
See the feature article about ICE in Open Health News.
New WHA resolution on access to Medicines and Vaccines
Dear All,
So pleased to share the great news that yesterday, the World Health Assembly adopted a resolution on improving the transparency of markets for medicines, vaccines and other health products in an effort to expand access. The draft resolution is on the WHA website: http://apps.who.int/gb/e/e_wha72.html#resolutions
The resolution urges Member States to enhance public sharing of information on actual prices paid by governments and other buyers for health products, and greater transparency on pharmaceutical patents, clinical trial results and other determinants of pricing along the value chain from laboratory to patient. This is what WHO is working on with the Market Information for Access (MI4A) initiative - focusing on vaccines. https://www.who.int/immunization/programmes_systems/procurement/v3p/platform/en/
It was great to see the enthusiasm of countries such as Brazil, the African delegation with a strong statement from Botswana, but also Hungary, Mexico, India and many others. This resolution was led by Italy and cosponsored by 18 countries across all WHO regions. It is a great step forward in helping countries making informed decisions on vaccines and medicines procurement!
Management of Vestfrost Equipment
Dear TechNet-21 Community,
Following the WHO PQS statement on the Vestfrost investigation, please find attached guidance on the management of the equipment and vaccines. Thank you.
Michelle Seidel
Immunization Supply Chain, Programme Division Office: +45 45 33 56 12, Mobile : +45 30 78 76 54, E-mail: mseidel@unicef.org
United Nations Children’s Fund UN City,Marmovej 51,Copenhagen, Denmark
Follow us on Facebook, Twitter, YouTube and at www.unicef.org
White paper on Harmonizing vaccination coverage measures available in English & French
Hemanthi
In
A white paper is available on Technet-21. To access them in English or French – please see below links:
Harmonizing vaccination coverage measures in household surveys: A primer
https://www.technet-21.org/en/?option=com_sobipro&sid=5300&pid=57&Itemid=2586
Guide pour l’harmonisation des indicateurs de couverture vaccinale dans le cadre des enquêtes auprès des ménages
https://www.technet-21.org/en/?coption=com_sobipro&sid=5301&pid=57&Itemid=2586
A Bright Future—Helping to Power Primary Health Care with an Energy Harvest Control
Pat Lennon
In
In January 2019, PATH and the Solar Electric Light Fund (SELF) partnered with the government of Senegal to evaluate a smart energy management device attached to certain solar vaccine refrigerators that would enable health workers to use electric devices in areas with limited or unreliable power. Called an energy harvest control (EHC), the device consists of a smart switch that takes excess power generated from solar panels already powering the refrigerators and safely allows the energy to be used for devices such as lights, fans, mobile phones, and some medical devices. The EHC configuration varies by solar direct drive (SDD) refrigerator manufacturer, but each device can access the excess energy, including through USB ports or 12 VDC sockets. The evaluation is taking place in four health posts in the Meckhe and Tivaouane districts of Senegal.
To date, three EHC devices have been prequalified by the World Health Organization (WHO) Performance, Quality and Safety (PQS) process—two SDD refrigerators with a built-in EHCa,b and one stand-alone systemc paired with a specific SDD refrigerator.d,e
The need for better electrification
One study found that of the 11 countries surveyed in sub-Saharan Africa, on average more than one-fourth lacked any access to electricity and close to three-fourths lacked access to a reliable supply of electricity.1 Electrification is a health equity issue—87 percent of those without electricity live in rural areas.2 Studies in Uganda demonstrated that access to midwives and electricity at health facilities had great impact, reducing the maternal fatality rate during emergency obstetric care by as much as 80 percent.3,4
Our goals for the EHC evaluation
The evaluation in Senegal will assess whether these EHC devices:
Perform according to the WHO PQS specifications in a real-use setting.
Are acceptable and useful to end users.
Have any unanticipated positive or negative effects on the health system.
Better health care through energy harvest control
This evaluation is a step forward in revolutionizing primary health care at the lowest levels of health systems. With the power provided by the EHC, health systems have improved options for:
Communication. The ability to charge cell phones, remote temperature monitoring devices, and other small communication devices supports facilities to keep in touch with patients, share data with higher-level facilities, and order supplies.
Management of health emergencies. Devices such as lights (for emergencies or births that happen at night)5 and neonatal ultrasound Dopplers for emergency obstetric care are prime examples of how EHC can enable better health care in hard-to-reach areas.
Access to health care. By decreasing the amount of time health workers spend away from health facilities charging their devices, health staff can be more available for patient care.
Quality of service: Patients must have a high degree of trust in their health centers to rely on them for their health needs, and that trust is either validated by receiving the proper care or broken through negative health interactions associated with a lack of basic equipment. Something as simple as basic lighting can help foster patient trust and improve perceptions regarding the reliability of their health system—and increase the likelihood that patients will seek help when needed.
Preliminary feedback from health workers
Users have had a positive response to the electricity provided through the EHC.
A head nurse noted, “Now they [health workers] get light at night when women are giving birth or when they have urgency—instead of using candles, light from mobile phones, or flashlight lamps.”
Users generally appreciated the extra power, used some of the study-provided loads, and charged additional loads like mobile phones and radios. The community had more positive perceptions regarding the health services provided by facilities as a result of the EHC devices.
“From the EHC project,” noted one head nurse, “we now have medical material to better diagnose our patients, especially pregnant women (fetal Doppler, otoscope).”
Next steps
We expect to have results from the evaluation in June 2019, and funding has been identified to expand this study to evaluate more EHC devices preparing for PQS pre-qualification. Future work could include market-shaping activities, expanded implementation, and testing and evaluation of equipment that can be used with an EHC.
Acknowledgement
PATH acknowledges and appreciates the leadership shown by Steve McCarney in bringing EHC technology to market and his long-time role as champion of solar power for use in low-resource health care facilities.
Contact
Steven Diesburg, sdiesburg@path.org
Footnotes
a. See http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/LinkPDF.aspx?UniqueID=9e49ae2f-111c-45fb-a740-3ef325e9e1cd&TipoDoc=DataSheet&ID=0.
b. See http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/LinkPDF.aspx?UniqueID=c407d376-4d5e-4f43-a4aa-32f97676dd90&TipoDoc=DataSheet&ID=0.
c. See http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/LinkPDF.aspx?UniqueID=ab8a4a27-c68d-4362-8b1b-82bfe9aa573d&TipoDoc=DataSheet&ID=0.
d. See http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/LinkPDF.aspx?UniqueID=ef393d19-a915-4937-a10c-0502af93e177&TipoDoc=DataSheet&ID=0.
e. See http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/LinkPDF.aspx?UniqueID=02f33f80-ec4a-4e23-9d53-bd9bbed31baa&TipoDoc=DataSheet&ID=0.
References
1. Adair-Rohani H, Zukor K, Bonjour S, et al. Limited electricity access in health facilities of sub-Saharan Africa: a systematic review of data on electricity access, sources, and reliability. Global Health, Science and Practice. 2013;1(2):249–261. https://doi.org/10.9745/GHSP-D-13-00037.
2. United Nations Department of Economic and Social Affairs (UNDESA). Analysis of the Voluntary National Reviews Relating to Sustainable Development Goal 7 - 2018. Geneva: UNDESA; 2018. https://sustainabledevelopment.un.org/content/documents/21159DESASDG7_VNR_Analysis2018_final.pdf.
3. Mbonye AK, Mutabazi MG, Asimwe JB, et al. Declining maternal mortality ratio in Uganda: priority interventions to achieve the Millennium Development Goal. International Journal of Gynaecology and Obstetrics. 2007;98(3):285–290. https://doi.org/10.1016/j.ijgo.2007.05.019.
4. Mbonye AK, Asimwe JB. Factors associated with skilled attendance at delivery in Uganda: results from a national health facility survey. International Journal of Adolescent Medicine and Health. 2010;22(2):249–155.
5. Suhlrie L, Bartram J, Burns J, Joca L, Tomaro J, Rehfuess E. The role of energy in health facilities: A conceptual framework and complementary data assessment in Malawi. PLoS One. 2018;13(7):e0200261. https://doi.org/10.1371/journal.pone.0200261.
Immunization Agenda 2030
Ebru Ekeman
In
As we approach the end of the Decade of Vaccines and with just a couple of years remaining on the Global Vaccine Action Plan (GVAP 2011-2020), a new Immunization Agenda 2030 is needed for the entire health and development community – one that re-affirms the benefits of vaccines and immunizations for a healthier, more secure and prosperous world through their contributions to the achievements of Universal Health Coverage (UHC) and Sustainable Development (SDG).
An initial attempt to assemble ideas, thoughts and content for an Immunization Agenda 2030 is now available for broad review. It is being shared as a ‘draft zero’ and is offered as a starting point for further co-creation and co-development with immunization specialists, broader health experts, and wider health stakeholders at country, regional and global levels. We welcome your reactions and views on this document by 14 June 2019 either by:
• Providing quick feedback via an online survey: https://www.surveymonkey.com/r/IA2030
• Sending written comments to: immunizationagenda2030@who.int or
• Posting comments online directly on the document at: https://drive.google.com/file/d/1Ct0Q1X7ZZch17EWdB5tnVM_qae17hTIx/view?usp=sharing - To do so, please select a word/sentence/paragraph, then click on the "+" on the right hand side of the page.
This document will continually evolve over the coming months based on you feedback. In addition, several dedicated regional consultations will be organized to ensure the voices of regional and country stakeholders are heard and that a bottom up process in co-developing the Immunization Agenda 2030 is implemented. For any queries, please send an email to: immunizationagenda2030@who.int
Meeting of the Pan-African Parliamentarians (PAP) and AFRO
We must do more to make sure everyone has access to essential health services. Investing in #immunization can help strengthen health systems and advance #UHC. #ProtectedTogether #VaccinesWork
I’m sharing the good news from this week’s meeting of the Pan-African Parliamentarians (PAP) and AFRO to advance the dialogue and commitments on the implementation of the African Union AU Declaration on Universal Access to Immunization.
http://www.panafricanparliament.org/index.php/news-and-events/47-global-health-coverage-immunization-and-albinism-take-priority-at-pap-session
This is (almost to the day) a year after launching the Immunization Business Case for the African Continent at the World Health Assembly (WHA71) by the DG (Dr Tedros) and AFRO RD (Dr Moeti). This is another big milestone as Parliamentarians will have a critical role to play in holding our Member States accountable for immunization outcomes. Getting their commitment is key to implementing the Addis Declaration on Immunization and the broader Immunization Agenda 2030!
New Topic page: EPI Core Reference Materials!
Announcing a new Topic resource page: EPI Core Reference Materials, now available on TechNet here: https://www.technet-21.org/en/topics/epi-core-reference
On this page, you will have accesss to a list of key reference materials published by the WHO Expanded Programme on Immunization (EPI), organized by antigen, themes, and groups. This page will continue to be updated as new global resources become available, so check back regularly! Remember you can also find all documents, as well as additional immunization materials, in the Immunization, Vaccines and Biologicals (IVB) Document Centre on the WHO web.
On this page, you will have accesss to a list of key reference materials published by the WHO Expanded Programme on Immunization (EPI), organized by antigen, themes, and groups. This page will continue to be updated as new global resources become available, so check back regularly! Remember you can also find all documents, as well as additional immunization materials, in the Immunization, Vaccines and Biologicals (IVB) Document Centre on the WHO web.
True Story of Elite Babies
Dear viewers
Several workshops were routinely held in the past and many more will be held in the future also especially to address urban immunization issues. Mission Director of Karnataka, in his inaugural speech expressed his deep apprehension as to whether the workshop will end with feasible solution. Some issues are perpetual look too complicated but very simple solutions are available which can be implemented with adrenaline speed in a sustainable way provided “bottom up approach, local tested innovations” are valued as iterated by GVAP as their 5th and 6th strategic objectives.
Attached example represents lakhs of babies of elite family for whom right vaccines with known potency are either delayed or denied or administered with no known potency, vaccination data are not transferable to HMIS hence do not add to the countries progress. These children are deprived of the luxury of FIC before first birth day and complete immunization before 2nd birth day – 2 of the 4 critical key indicators of Intensified Mission Indradhanush – the most ambitious flagship programme of the country.
But this is a “SOLVABLE PROBLEM”.
Holla n Team
Simple VPD (e.g. measles or diphtheria) susceptibility analysis tool
Does anyone know or use a simplified susceptibility analysis tool that can be used at sub-national level? Is there a model of a simple susceptibility analysis tool likely to be used by people who are neither very much techno savvy nor have strong epidemiological background but need some guidance/ evidence to convince decision-makers to invest in the conduct of preventive vaccinations/outreach/ defaulter tracking by showing how many children are susceptible and there's an imminent outbreak?
This will be linked to a request for local government funding and other basic support to carry out the necessary intervention way before an outbreak actually occurs. Something that is flexible (e.g. can be used for measles and/or diphtheria) and uses locally available or limited data.
Any input is highly appreciated and thanks in advance.
IVIR-AC endorsement of WHO Market Information for Access Initiative and methodology
Hello, please check out recent feedback from the Immunization and vaccines related implementation research advisory committee (IVIR-AC) on the newly-launched WHO Market Information for Access Initiative (MI4A) and methodology:
"The initiative is providing a valuable public good that could shape markets and ultimately save lives if greater transparency and less information asymmetry generally lead to more efficient markets."
View the full IVIR-AC recommendations in the current edition of WHO's Weekly Epidemiological Record:
https://apps.who.int/iris/bitstream/handle/10665/312312/WER9419.pdf
MI4A provides a unique global perspective on vaccine markets, covering all countries and vaccines with objectives to:
Enhance the understanding of global vaccine demand, supply and pricing dynamics and identifying affordability and shortage risks;
Convene all relevant global health partners to contribute to the development of policies, strategies, and guidance to address the identified risks;
Strengthen national and regional capacity for improved access to vaccines supply.
For more information on MI4A please see:
www.who.int/immunization/MI4A
Tania
Temperature monitoring/recording
There are different types of cold chain monitoring devices such as freeze alert, Log tag, 30 DTR, and liquid thermometers. Among these devices, which device are more appropriate and convenient to use for monitoring temperature in refrigerators?
WHO releases a new Vaccine Wastage Calculator
Hello!
We are happy to announce the release of the WHO Vaccine Wastage Rates Calculator. It can be downloaded from the WHO website at the following link:
https://www.who.int/immunization/programmes_systems/supply_chain/resources/tools/en/
It is the culmination of many years of efforts to provide a rational guidance on vaccine wastage estimation. As you know, wastage is an important parameter for vaccine forecasting needs and remain a sensitive indicator for vaccine utilization. Therefore, wastage could impact both the immunization programme cost, coverage and equity.
In 2002, WHO issued global indicative vaccine wastage rates to be used by countries in absence of national data. Nevertheless, they remain generic with significant limitations since they were not necessarily reflecting each specific vaccine service delivery setting. The new WHO Vaccine Wastage Rates Calculator was developed in response to these limitations. The development was supported by a WHO model based on binomial statistics, endorsed by the WHO’s Immunization Practices Advisory Committee (IPAC).
The calculator will provide more precise vaccine wastage rates to support:
EPI managers at country level, to provide accurate annual vaccine forecast, reducing stock out and over stocks; to adapt vaccine product presentation to country context; to reduce missed opportunities; finally, to improve coverage and equity;
Partners at the global level, to improve predictable global demand and avoid global shortages.
We would like to thank all individuals and partners who contributed greatly to the development of this new WHO Vaccine Wastage Rates Calculator.
We welcome any suggestions and feedback from users that can help to further improve it!
Best,
Tania Cernuschi
Group Manager - Supply, Technologies, and Financing
Expanded Programme on Immunization (EPI) | Dept of Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
There are no discussions available here currently
- 2717
- Tima Diabate
Online Members